The ED50 of sufentanil required for induction intubation in patients with different pain sensitivities

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400087707

Enrollment

Unknown

Registered

2024-08-01

Start date

2024-08-01

Completion date

Unknown

Last updated

2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid disease

Interventions

Group L (PSQ 6) : high sensitivity in patients with pain:None

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Elective thyroidectomy; ? Age of 18-60 years old; ?BMI18-30kg/m2. ? American Society of Anesthesiologists score ?-?.

Exclusion criteria

Exclusion criteria: ? Previous allergies to the drugs used in this study; (2) long-term use of alcohol or sedative drugs; (3) preoperative analgesic drugs; ? previous neuropsychiatric disorders, coma, depression, cognitive impairment; ?SBP<85mmHg or HR<50 bpm/min; 6. Refused to participate in this study; ? Acute upper respiratory tract disease, liver and kidney failure, severe heart disease.

Design outcomes

Primary

Measure	Time frame
ED50 and ED95 of sufentanil required for induction of anesthesia in patients with different sensitivity groups;	—

Secondary

Measure	Time frame
Visual analog scale score, VAS;Incidence of nausea and vomiting;	—

Countries

China

Contacts

Public ContactWeimin-Liang

The Second Hospital of Hebei Medical University

liangweimin@hb2h.com+86 187 3312 2368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026